Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CytomX Therapeutics (CTMX) Non Operating Income: 2013-2024

Historic Non Operating Income for CytomX Therapeutics (CTMX) over the last 12 years, with Dec 2024 value amounting to -$38,000.

  • CytomX Therapeutics' Non Operating Income rose 171.43% to $5,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $14,000, marking a year-over-year increase of 227.27%. This contributed to the annual value of -$38,000 for FY2024, which is 26.67% down from last year.
  • According to the latest figures from FY2024, CytomX Therapeutics' Non Operating Income is -$38,000, which was down 26.67% from -$30,000 recorded in FY2023.
  • Over the past 5 years, CytomX Therapeutics' Non Operating Income peaked at $340,000 during FY2022, and registered a low of -$83,000 during FY2021.
  • Over the past 3 years, CytomX Therapeutics' median Non Operating Income value was -$30,000 (recorded in 2023), while the average stood at $90,667.
  • Its Non Operating Income has fluctuated over the past 5 years, first plummeted by 207.41% in 2021, then soared by 509.64% in 2022.
  • Yearly analysis of 5 years shows CytomX Therapeutics' Non Operating Income stood at -$27,000 in 2020, then slumped by 207.41% to -$83,000 in 2021, then soared by 509.64% to $340,000 in 2022, then slumped by 108.82% to -$30,000 in 2023, then declined by 26.67% to -$38,000 in 2024.